Benjamin Derman to Prognosis
This is a "connection" page, showing publications Benjamin Derman has written about Prognosis.
Connection Strength
0.279
-
Minimal Residual Disease Negativity as the Primary Goal of Multiple Myeloma Therapy. Drugs. 2025 Oct; 85(10):1231-1251.
Score: 0.127
-
Sex differences in outcomes in multiple myeloma. Br J Haematol. 2021 02; 192(3):e66-e69.
Score: 0.091
-
Prognostic Significance of Cell-Free DNA Derived 5-Hydroxymethylcytosine Signatures in Newly Diagnosed Multiple Myeloma. JCO Precis Oncol. 2026 Jul; 10(7):e2501121.
Score: 0.034
-
Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL. Clin Lymphoma Myeloma Leuk. 2024 02; 24(2):83-93.
Score: 0.028